SS Innovations International (SSII) Return on Invested Capital (2021 - 2026)

SS Innovations International's (SSII) quarterly Return on Invested Capital came in at 0.0% in Q1 2026, up 23.37% quarter-over-quarter from 0.0% in Q4 2025.

SS Innovations International (SSII) Return on Invested Capital (2021 - 2026) Analysis & Trends

SS Innovations International has disclosed Return on Invested Capital across 4 years of filings, most recently posting 0.0% for Q1 2026.

  • Return on Invested Capital for Q1 2026 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital came in at 0.0% for Q1 2026 at SS Innovations International, up from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q2 2022 to a low of 0.05% in Q1 2022.
  • The 3-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.0%.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.00%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.00%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.00%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.00%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.00%
10 SS Innovations International 689.95 Mn 666.34 Mn 5.33 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.01%
Sep 30, 2022 0.01%
Jun 30, 2022 0.03%
Mar 31, 2022 -0.05%
Dec 31, 2021 0.45%